Fifth Lane Capital’s Braskem BAK Stock Holding History

Fifth Lane Capital’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-60,000	Closed	-$493K	–	125
2023 Q3	$493K	Buy	60,000 +45,000	+300%	+$436K	0.17%	78
2023 Q2	$175K	Buy	+15,000	New	+$142K	0.05%	107

Other funds holding BAK

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

SGDR

SPX Gestao de Recursos Rio De Janeiro, Brazil $1.2B AUM 59.05% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Fifth Lane Capital's BAK Position: Q4 2023 in Review

Fifth Lane Capital sold out of Braskem (BAK) in Q4 2023, closing a stake of 60,000 shares — an estimated $493K sold.

Fifth Lane Capital first reported a position in BAK in Q2 2023 and held it in 2 quarters. The position peaked at $493K in Q3 2023. 56 funds tracked by Wall St. Rank hold BAK as of Q4 2023.

Fifth Lane Capital reported no remaining Braskem position as of Q4 2023 after selling out during the quarter.
Fifth Lane Capital sold 60,000 Braskem shares in Q4 2023, an estimated $493K.
Fifth Lane Capital first reported a position in Braskem in Q2 2023 and held it in 2 quarters.
Fifth Lane Capital's Braskem position peaked at $493K in Q3 2023.
56 funds tracked by Wall St. Rank held Braskem as of Q4 2023.

Based on Fifth Lane Capital's 13F filing for Q4 2023, filed 14 Feb 2024.